Pages that link to "Q36292107"
Jump to navigation
Jump to search
The following pages link to Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy (Q36292107):
Displaying 10 items.
- Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters (Q24306742) (← links)
- The LZT proteins; the LIV-1 subfamily of zinc transporters (Q28186598) (← links)
- Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients (Q28258932) (← links)
- LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling (Q34081759) (← links)
- Zinc and cancer: implications for LIV-1 in breast cancer (Q36126413) (← links)
- Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer (Q36250275) (← links)
- Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7. (Q40004151) (← links)
- Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel (Q41134105) (← links)
- Zinc as a Gatekeeper of Immune Function. (Q47256027) (← links)
- Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer (Q93097026) (← links)